Jeffrey Hung

Stock Analyst at Morgan Stanley

(0.71)
# 2088
Out of 5,319 analysts
254
Total ratings
38.28%
Success rate
-7.37%
Average return
42 Stocks
Name Action Price Target Current % Upside Ratings Updated
ENGN enGene Holdings
Maintains: Overweight
37 34
4 750% 3 Mar 11, 2025
RYTM Rhythm Pharmaceutica...
Assumes: Overweight
72 72
61.74 16.62% 11 Mar 7, 2025
PTCT PTC Therapeutics
Assumes: Overweight
67 70
47.39 47.71% 11 Mar 7, 2025
NBIX Neurocrine Bioscienc...
Assumes: Overweight
185 150
101.38 47.96% 24 Mar 7, 2025
JAZZ Jazz Pharmaceuticals
Assumes: Overweight
175 183
102.78 78.05% 5 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
4 4
1.16 244.83% 3 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
85
42.16 101.61% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
38 35
7.89 343.6% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
25 25
4.62 441.13% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
55 55
20.64 166.47% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 27
12.29 119.69% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Underweight
5
3.87 29.2% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Equal-Weight
20 20
14.73 35.78% 24 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
70 67
39.48 69.71% 13 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
17 12
6.83 75.7% 4 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
92 95
131.87 -27.96% 5 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
35
9.8 257.14% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
50 70
30.42 130.11% 2 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
295 330
329.83 0.05% 3 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 4
0.81 393.83% 10 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
13 4
1.71 133.92% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1 4
0.51 684.31% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
60 140
4.14 3281.64% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
90 84
35.69 135.36% 7 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 40
7.39 441.27% 4 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 14
1.27 1002.36% 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
5 5
1.21 313.22% 1 Jul 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
9 3
0.95 215.79% 8 Mar 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
15 14
1.2 1066.67% 7 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 21
3.18 560.38% 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
4 2
3.02 -33.77% 3 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
50 10
1.55 545.16% 3 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
22 30
n/a n/a 6 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
23 22
36.19 -39.21% 10 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
2 2
n/a n/a 5 Sep 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
250 94
n/a n/a 8 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
146 149
20.37 629.01% 2 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
180
n/a n/a 12 Oct 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
100 60
1.5 3900% 5 Aug 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 6
3.16 89.87% 9 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
121 225
n/a n/a 9 Oct 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 54
0.36 14900% 6 May 8, 2020